Publikationen von B. Müller-Myhsok

Kern, N.; Binder, E. B.; Pfennig, A.; Erhardt, A.; Ising, M.; Lucae, S.; Salyakina, D.; Pütz, B.; Holsboer, F.; Müller-Myhsok, B. et al.; Keck, M. E.: Possible association of angiotensin 1 converting enzyme polymorphisms with syndromal panic attacks. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 130B (1), S. 66 - 67 (2004)

Lucae, S.; Binder, E. B.; Pütz, B.; Salyakina, D.; Mueller-Myhsok, B.; Ising, M.; Horstmann, S.; Unschuld, P.; Holsboer, F.: Association of SNP within the serotonin transporter gene with depressive disorder and associated functional parameters. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 130B (1), S. 38 - 39 (2004)

Unschuld, P. G.; Ising, M.; Erhardt, A.; Kern, N.; Lucae, S.; Horstmann, S.; Salyakina, D.; Pütz, B.; Binder, E. B.; Müller-Myhsok, B. et al.; Holsboer, F.; Keck, M. E.: Polymorphisms in serotonin receptor genes HTR1B, HTR2A, HTR2C and HTR4 are possibly associated with specific personality traits in patients suffering from anxiety disorders. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 130B (1), S. 67 - 68 (2004)

Wszolek, Z. K.; Pfeiffer, R. F.; Tsuboi, Y.; Uitti, R. J.; McComb, R. D.; Stoessl, A. J.; Strongosky, A. J.; Zimprich, A.; Müller-Myhsok, B.; Farrer, M. J. et al.; Gasser, T.; Calne, D. B.; Dickson, D. W.: Autosomal dominant parkinsonism associated with variable synuclein and tau pathology. Neurology 62 (9), S. 1619 - 1622 (2004)

Binder, E. B.; Salyakina, D.; Lichtner, P.; Wochnik, G. M.; Ising, M.; Pütz, B.; Papiol, S.; Seaman, S.; Lucae, S.; Kohli, M. et al.; Nickel, T.; Künzel, H.; Fuchs, B.; Majer, M.; Pfennig, A.; Kern, N.; Brunner, J.; Modell, S.; Baghai, T.; Deiml, T.; Zill, P.; Bondy, B.; Rupprecht, R.; Messer, T.; Köhnlein, O.; Dabitz, H.; Brückl, T.; Müller, N.; Pfister, H.; Lieb, R.; Mueller, J. C.; Löhmussaar, E.; Strom, T. M.; Bettecken, T.; Meitinger, T.; Uhr, M.; Rein, T.; Holsboer, F.; Müller-Myhsok, B.: Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nature Genetics 36, S. 1319 - 1325 (2004)

Zimprich, A.; Müller-Myhsok, B.; Farrer, M.; Leitner, P.; Sharma, M.; Hulihan, M.; Lockhart, P.; Strongosky, A.; Kachergus, J.; Calne, D. B. et al.; Stoessl, J.; Uitti, R. J.; Pfeiffer, R. F.; Trenkwalder, C.; Homann, N.; Ott, E.; Wenzel, K.; Asmus, F.; Hardy, J.; Wszolek, Z.; Gasser, T.: The PARK8 locus in autosomal dominant parkinsonism: Confirmation of linkage and further delineation of the disease-containing interval. American Journal of Human Genetics 74 (1), S. 11 - 19 (2004)

Kern, N.; Binder, E. B.; Künzel, H. E.; Pfennig, A.; Fuchs, B.; Ising, M.; Erhardt, A.; Lucae, S.; Müller-Myhsok, B.; Modell, S. et al.; Keck, M. E.; Holsboer, F.: Is there a genetic continuum between anxiety and depression? Pharmacopsychiatry 36 (5), S. 239 - 239 (2003)

Pfennig, A.; Kuenzel, H. E.; Kern, N.; Fuchs, B.; Brunner, J.; Ising, M.; Modell, S.; Müller-Myhsok, B.; Binder, E. B.; Holsboer, F.: HPA axis dysregulation and suicidal behavior in depression - Differentiation of a genetically distinct subgroup? Pharmacopsychiatry 36 (5), S. 252 - 253 (2003)

Winkelmann, J.; Lichtner, P.; Strom, T. M.; Trenkwalder, C.; Meitinger, T.; Müller-Myhsok, B.: Evidence for genetic heterogeneity in Restless Legs Syndrome. Pharmacopsychiatry 36 (5), S. 273 - 273 (2003)

Andlauer, T. F. M.; Müller-Myhsok, B.; Ripke, S.: Statistical genetics: genome-wide studies. In: Psychiatric genetics: a primer for clinical and basic scientists, S. 57 - 69 (Hg. Schulze, T. G.; McMahon, F. J.). Oxford Univ. Press, New York (2018)

Renzi, C.; Provencal, N.; Bassil, K. C.; Evers, K.; Kihlbom, U.; Radford, E. J.; Koupil, I.; Mueller-Myhsok, B.; Hansson, M. G.; Rutten, B. P. F.: From Epigenetic Associations to Biological and Psychosocial Explanations in Mental Health. In: NEUROEPIGENETICS AND MENTAL ILLNESS, S. 299 - 323 (Hg. Rutten, B. P. F.). ELSEVIER ACADEMIC PRESS, Cambridge (2018)

Müller-Myhsok, B.: Genetische Grundlagen der Wirksamkeit von Antidepressiva. Forschungsbericht 2006 - Max-Planck-Institut für Psychiatrie. In: Jahrbuch (Hg. Max-Planck-Gesellschaft). Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., München (2006)

Gola, D.; Andlauer, T.; Mirza-Schreiber, N.; Zeng, L.; Müller-Myhsok, B.; Koenig, I. R.: How well can we classify coronary artery disease using all genetic data and choosing the best classification algorithm? 27th Annual Meeting of the International Genetic Epidemiology Society (IGES), San Diego, USA, 14. Oktober 2018 - 16. Oktober 2018. GENETIC EPIDEMIOLOGY 42 (7), 41, S. 701 - 702 (2018)

Anderson-Schmidt, H.; Papiol, S.; Andlauer, T.; Heilbronner, U.; Budde, M.; Kalman, J.; Degenhardt, F.; Noethen, M.; Strohmaier, J.; Frank, J. et al.; Witt, S.; Müller-Myhsok, B.; Falkai, P.; Rietschel, M.; Schulze, T. G.: USING POLYGENIC SCORES BASED ON SCHNEIDERIAN FIRST RANK SYMPTOMS TO CHARACTERIZE DISEASE TRAJECTORIES IN SEVERE MENTAL ILLNESSES. 24th World Congress of Psychiatric Genetics (WCPG 2016), Jerusalem, ISRAEL, 30. Oktober 2016 - 04. November 2016. EUROPEAN NEUROPSYCHOPHARMACOLOGY 27 (S3), S. S395 - S396 (2017)

Andlauer, T.; Parra, J. G.; Strohmaier, J.; Streit, F.; Frank, J.; Forstner, A. J.; Herms, S.; Ripke, S.; Müller-Myhsok, B.; Cichon, S. et al.; Cleries, F. M.; Noethen, M.; Rietschel, M.: POLYGENIC RISK FOR BIP, MDD, AND SCZ IN ANDALUSIAN MULTIPLEX FAMILIES. 24th World Congress of Psychiatric Genetics (WCPG), Jerusalem, ISRAEL, 30. Oktober 2016 - 04. November 2016. EUROPEAN NEUROPSYCHOPHARMACOLOGY 27 (S3), M28, S. S385 - S386 (2017)

Carrillo-Roa, T.; Boadie, D.; McGrath, C.; Müller-Myhsok, B.; Craighed, E.; Mayberg, H.; Binder, E.: POLYGENIC SCORES DERIVED FROM NEUROIMAGING ENDOPHENOTYPES PREDICT OUTCOMES TO PSYCHOTHERAPY AND MEDICATION TREATMENTS FOR MAJOR DEPRESSIVE DISORDER. 24th World Congress of Psychiatric Genetics (WCPG), Jerusalem, ISRAEL, 30. Oktober 2016 - 04. November 2016. EUROPEAN NEUROPSYCHOPHARMACOLOGY 27 (S3), S. S486 - S486 (2017)

Forstner, A. J.; Wolf, C.; Maron, E.; Erhardt, A.; Eriksson, E.; Hovatta, L.; Lavebratt, C.; Allgulander, C.; Woldbye, D. P. D.; Mors, O. et al.; Müller-Myhsok, B.; Binder, E. B.; Rueck, C.; Deckert, J.; Schumacher, J.: GENOME-WIDE ASSOCIATION STUDY OF PANIC DISORDER. 23rd Annual World Congress of Psychiatric Genetics (WCPG), Toronto, CANADA, 16. Oktober 2015 - 20. Oktober 2015. EUROPEAN NEUROPSYCHOPHARMACOLOGY 27 (Suppl.2), Su19, S. S217 - S218 (2017)

Iurato, S.; Carrillo-Roa, T.; Arloth, J.; Czamara, D.; Ising, M.; Lucae, S.; Müller-Myhsok, B.; Binder, E.; Erhardt, A.: SEX-SPECIFIC DNA METHYLATION SIGNATURES IN PANIC DISORDER. 24th World Congress of Psychiatric Genetics (WCPG), Jerusalem, ISRAEL, 30. Oktober 2016 - 04. November 2016. EUROPEAN NEUROPSYCHOPHARMACOLOGY 27 (Suppl. 3), T24, S. S446 - S447 (2017)

Karbalai, N.; Czamara, D.; Moll, K.; Ramus, F.; Malik, R.; Scerri, T. S.; Schumacher, J.; Morris, A. P.; Bourgeron, T.; Monaco, A. P. et al.; Paracchini, S.; Fisher, S. E.; Nothen, M.; Schulte-Korne, G.; Müller-Myhsok, B.: IDENTIFICATION OF GENETIC INTERACTIONS INVOLVED IN DYSLEXIA PATHOGENESIS. 23rd Annual World Congress of Psychiatric Genetics (WCPG), Toronto, CANADA, 16. Oktober 2015 - 20. Oktober 2015. EUROPEAN NEUROPSYCHOPHARMACOLOGY 27 (Suppl. 2), Sa68, S. S183 - S184 (2017)

Zannas, A. S.; Gassen, N. C.; Jia, M.; Baumert, J.; Hafner, K.; Ködel, M.; Haehle, A.; Iurato, S.; Carrillo-Roa, T.; Emeny, R. T. et al.; Lahti, J.; Raikkönen, K.; Eriksson, J.; Drake, A.; Waldenberger, M.; Wahl, S.; Kunze, S.; Lucae, S.; Bradley, B.; Gieger, C.; Hausch, F.; Smith, A. K.; Ressler, K. J.; Ludwig, K.-H.; Müller-Myhsok, B.; Rein, T.; Binder, E. B.: Aging- and stress-related epigenetic disinhibition of FKBP5 contributes to NF-κB-driven inflammation and cardiovascular risk. Conference of the World-Association-for-Stress-Related-and-Anxiety-Disorders (WASAD), Würzburg, Germany, 14. September 2017 - 16. September 2017. JOURNAL OF NEURAL TRANSMISSION 124 (10), S. 1292 - 1292 (2017)